Guardian Drug Co. Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jan 16, 2026
  • No warning letters matched by name
Inspections 9 0 OAI
Recalls 23 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Guardian Drug Co. Inc. has 23 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Guardian Drug Co. Inc." is on file.

What these totals cover: FDA records filed under the name "Guardian Drug Co. Inc." and its spelling variant "Guardian Drug Co".

Latest recall
D-0564-2026 · Class II · May 28, 2026
Latest inspection
Jan 16, 2026 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls23Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Guardian Drug Co. Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Guardian Drug Co. Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 23 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
2026100230
202500000
202410000
202300000
202210000
202100000
202000000
201900000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Guardian Drug Co. Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Guardian Drug Co. Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

23 recall records on May 28, 2026. Showing the 20 most recent. View all 23 recall records

NumberClassProductDate
D-0564-2026Class IIMARKET BASKET ANTACID Calcium Carbonate 1000 mg, ULTRA STRENGTH, 72 Tablets, Distributed by: De…May 28, 2026
D-0577-2026Class IIEQUALINE ultra strength, antacid tablets, calcium carbonate 1000mg, 72 chewable tablets, DISTRIBUTED…May 28, 2026
D-0558-2026Class IIHALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 1000 mg, 160-count bottle, Haleon…May 28, 2026
D-0576-2026Class IIEQUALINE extra strength, antacid tablets, calcium carbonate 750mg, 96 chewable tablets, DISTRIBUTED…May 28, 2026
D-0561-2026Class IIGood Neighbor Pharmacy, extra strength Antacid Calcium Carbonate 1000 mg, 72 chewable tablets…May 28, 2026
D-0575-2026Class IIGOODSENSE Ultra Strength, Antacid TABLETS, Calcium Carbonate 1000 mg, 72 Chewable Tablets…May 28, 2026
D-0566-2026Class IICAREone, ULTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 1000 mg, 72 chewable Tablets, Distributed…May 28, 2026
D-0562-2026Class IIExtra strength Antacid Calcium Carbonate 750 mg, chewable tablets, 96-count bottle, DISTRIBUTED BY…May 28, 2026
D-0578-2026Class IITopCare health, EXTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 750mg, 96 CHEWABLE TABLETS…May 28, 2026
D-0574-2026Class IIGOODSENSE Extra Strength, Antacid TABLETS, Calcium Carbonate 750 mg, 96 Chewable Tablets…May 28, 2026
D-0563-2026Class II24/7 life BY 7-ELEVEN, Extra strength Antacid Tablets, Calcium Carbonate 750 mg, 96 chewable…May 28, 2026
D-0572-2026Class IIHyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY…May 28, 2026
D-0565-2026Class IICAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewable Tablets, Distributed…May 28, 2026
D-0571-2026Class IIHyVee, Extra Strength Antacid, Calcium Carbonate 750 mg, 96 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE…May 28, 2026
D-0573-2026Class IIH.E.B Extra Strength Calcium Carbonate Antacid Tablets, Calcium Carbonate 750 mg, 96 Chewable…May 28, 2026
D-0560-2026Class IIGood Neighbor Pharmacy, extra strength Antacid Calcium Carbonate 750 mg, chewable, 96-count bottle…May 28, 2026
D-0569-2026Class IIFAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS…May 28, 2026
D-0559-2026Class IIHALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 750 mg, 330-count bottle, Haleon…May 28, 2026
D-0568-2026Class IIFAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS…May 28, 2026
D-0579-2026Class IITopCare health, ULTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 1000mg, 72 CHEWABLE TABLETS…May 28, 2026

Recent FDA inspections

9 inspections from Oct 28, 2008 to Jan 16, 2026.

DateSiteProductClassificationFEI
Jan 16, 2026Dayton, NJDrugsNo Action Indicated (NAI)2245306
Nov 7, 2024Dayton, NJDrugsNo Action Indicated (NAI)2245306
Feb 17, 2022Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
Nov 6, 2017Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
Aug 15, 2014Dayton, NJDrugsNo Action Indicated (NAI)2245306
Jun 8, 2012Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
Mar 2, 2012Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
Feb 18, 2011Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
Oct 28, 2008Dayton, NJDrugsVoluntary Action Indicated (VAI)2245306
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2245306Dayton, NJ9Jan 16, 2026

Guardian Drug Co. Inc. and the FDA: common questions

Has Guardian Drug Co. Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Guardian Drug Co. Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Guardian Drug Co. Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Guardian Drug Co. Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Guardian Drug Co. Inc.?

The most recent FDA inspection on file ended Jan 16, 2026 at Dayton, NJ and was classified NAI. FDA has 9 inspections of Guardian Drug Co. Inc. on file.

Has Guardian Drug Co. Inc. had an FDA recall?

Yes. Guardian Drug Co. Inc. has 23 FDA recalls on record. The most recent started May 28, 2026.

Need more than this page shows? Ask about Guardian Drug Co. Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.